शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEVASUNDHARA RASAYANS LTD· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 28 Jul, 2026 · 20:33 IST

Board to consider FY26 dividend recommendation on 1 Aug

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹174.50
prior close
₹173.15
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%-2.5% vs market
Pharmaceuticals peers, median of 160sector+0.8%-2.8% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0+0.5-2.5+0.8-2.8
Next day
+0.3-0.1+0.4-0.0+0.3
2d
+1.4+1.0+0.4+0.1+1.3
3d
-1.7+2.3-4.0+0.6-2.3
4d
+2.6+2.8-0.2+1.0+1.6
5d
+2.0+4.1-2.1+0.6+1.4
1w
+3.2+4.5-1.3+1.5+1.7
15d
-9.5+4.8-14.2+0.5-10.0
1m
-10.6+6.4-17.0+2.1-12.7
2m
-14.0+5.5-19.6+4.2-18.3
3m
-19.4-1.7-17.7-1.9-17.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vasundhara Rasayans has informed BSE that its Board of Directors will meet on 1 August 2026 to consider and recommend a dividend on equity shares for the financial year ended 31 March 2026, subject to shareholder approval at the upcoming 39th AGM. The Board will also finalise the AGM notice, date, time, scrutinizer, e-voting process, book closure dates, and draft directors report.

Likely market impact

Board meeting on 1 Aug may lead to a dividend announcement for FY26; details will follow post-meeting subject to shareholder approval.